Eric J. Topol

Long COVID: major findings, mechanisms and recommendations

High-performance medicine: the convergence of human and artificial intelligence

The use of artificial intelligence, and the deep-learning subtype in particular, has been enabled by the use of labeled big data, along with markedly enhanced computing power an...

Failing the Public Health — Rofecoxib, Merck, and the FDA

On May 21, 1999, Merck was granted approval by the Food and Drug Administration (FDA) to market rofecoxib (Vioxx). On September 30, 2004, after more than 80 million patients had...

Regionalization of Care for Acute Ischemic Heart Disease

Clinical and Therapeutic Profile of Patients Presenting With Acute Coronary Syndromes Who Do Not Have Significant Coronary Artery Disease

Background —A proportion of patients who present with suspected acute coronary syndrome (ACS) are found to have insignificant coronary artery disease (CAD) during coronary angio...